Leqembi® approved for IV maintenance treatment in the United Kingdom
Go back to Leqembi® approved for IV maintenance treatment in the United Kingdom| BARNES GROUP, Inc. (NYSE: B) | Delayed: 37.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.19 | 52 Week High | $44.27 | |||
| Open | $37.19 | 52 Week Low | $30.07 | |||
| Day High | $37.19 | P/E | 28.39 | |||
| Day Low | $37.19 | EPS | $1.31 | |||
| Volume | 53,205 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 15.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.48 | 52 Week High | $8.73 | |||
| Open | $15.48 | 52 Week Low | $2.86 | |||
| Day High | $15.48 | P/E | N/A | |||
| Day Low | $15.48 | EPS | $-3.82 | |||
| Volume | 10 | |||||
